Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Rimola, M. Navasa.
Infections in liver disease.
Oxford Textbook of Clinical Hepatology (2.a ed.), pp. 1861-1876
[2.]
B.A. Runyon.
Management of adult patients with ascites caused by cirrhosis.
Hepatology, 27 (1998), pp. 264-272
[3.]
G. García-Tsao.
Spontaneous bacterial peritonitis.
Gastroenterol Clin N Am, 21 (1992), pp. 257-275
[4.]
W.R. Caly, E. Strauss.
A prospective study of bacterial infections in patients with cirrhosis.
J Hepatol, 18 (1993), pp. 353-358
[5.]
M. Navasa, J. Rodés.
Management of ascites in the patients with portal hypertension with emphasis on spontaneous bacterial peritonitis.
Sem Gastroenterol Dis, 8 (1997), pp. 200-209
[6.]
M. Navasa, A. Rimola, J. Rodés.
Bacterial Infections in liver diseases.
Sem Liver Dis, 17 (1997), pp. 323-333
[7.]
G. Pinzello, R. Simonetti, C. Camma, O. Dino, G. Milazzo, L. Pagliaro, et al.
Spontaneous bacterial peritonitis: an update.
Gastroenterol Int, 6 (1993), pp. 54-60
[8.]
D-J Bac, P.D. Siersema, P.G.H. Mulder, S. DeMarie, JHP. Wilson.
Spontaneous bacterial peritonitis: outcome and predictive factors.
Eur J Gastroenterol Hepatol, 5 (1993), pp. 635-640
[9.]
C. Toledo, J.M. Salmerón, A. Rimola, M. Navasa, V. Arroyo, J. Llach, et al.
Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.
Hepatology, 17 (1993), pp. 251-257
[10.]
J.M. Llovet, R. Planas, R. Morillas, J.C. Quer, E. Cabré, J. Boix, et al.
Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study.
Am J Gastroenterol, 88 (1993), pp. 388-392
[11.]
M. Navasa, A. Follo, J.M. Llovet, G. Clemente, V. Vargas, A. Rimola, et al.
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
Gastroenterology, 111 (1996), pp. 1011-1017
[12.]
J.C. Hoefs, H.N. Canawatti, F.L. Sapico, R.R. Hopkins, J. Weiner, J.Z. Montgomerie.
Spontaneous bacterial peritonitis.
Hepatology, 3 (1982), pp. 545-549
[13.]
G. Pinzello, R.G. Simonetti, A. Craxi, S. DiPiazza, C. Spanò, L. Pagliaro, et al.
Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients.
Hepatology, 3 (1983), pp. 545-549
[14.]
J.V. Hoefs, B.A. Runyon.
Spontaneous bacterial peritonitis.
Disease- a-month, 31 (1985), pp. 1-48
[15.]
T.P. Almdal, P. Skinhøj.
Spontaneous bacterial peritonitis in cirrhosis. Incidence, diagnosis and prognosis.
Scand J Gastroenterol, 22 (1987), pp. 295-300
[16.]
P. Lafond, A. Viallon, F. Zéni, B. Tardy, A. DaCosta, Y. Page, et al.
Justification de la ponciton d'ascite systématique chez le patient cirrhotique admis aux urgences.
Presse Méd, 24 (1995), pp. 531-533
[17.]
A. Rimola, J.M. Salmeron, G. Clemente, L. Rodrigo, A. Obrador, M.L. Miranda, et al.
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.
Hepatology, 21 (1995), pp. 674-679
[18.]
A. Bar.Meir, E. Lerner, H.O. Conn.
Analysis of ascitic fluid in cirrhosis.
Am J Dig Dis, 24 (1979), pp. 136-144
[19.]
G. García-Tsao, H.O. Conn, E. Lerner.
The diagnosis of bacterial peritonitis: comparison of pH lactate concentration and leukocyte count.
Hepatology, 5 (1985), pp. 91-96
[20.]
C-Y Yang, Y-F Liaw, C-M Chu, I-S. Sheen.
White count, pH and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis.
Hepatology, 5 (1985), pp. 85-90
[21.]
W.N. Stassen, A.J. McCullough, B.R. Bacon, S.H. Gutnick, I.M. Wadiwala, C. McLaren, et al.
Immediate diagnostic criteria for bacterial infection of ascitic fluid: evaluation of ascitic fluid polymorphonuclear leukocyte count, pH and lactate concentration, alone or in combination.
Gastroenterology, 90 (1986), pp. 1247-1254
[22.]
A. Albillos, V. Cuervas-Mons, I. Millán, T. Cantón, J. Montes, C. Barrios, et al.
Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis.
Gastroenterology, 98 (1990), pp. 134-140
[23.]
J. Felisart, A. Rimola, V. Arroyo, R.M. Pérez-Ayuso, E. Quintero, P. Ginès, et al.
Cefotaxime is more effective than is ampicillin- tobramycin in cirrhotics with severe infections.
Hepatology, 5 (1985), pp. 457-462
[24.]
B.A. Runyon, J.G. McHutchison, M.R. Antillon, E.A. Akriviadis, A.A. Montano.
Short course versus long course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients.
Gastroenterology, 100 (1991), pp. 1737-1742
[25.]
J.C. Hoefs.
Increase in ascites WBC and protein concentrations during diuresis in patients with chronic liver disease.
Hepatology, 1 (1981), pp. 249
[26.]
M.K. Kline, R.W. McCallum, P.H. Guth.
The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis.
Gastroenterology, 70 (1976), pp. 408-412
[27.]
J.A.P. Wilson, E.A. Suguitan, W.A. Cassidy, R.H. Parker, C.H. Chan.
Characteristics of ascitic fluid in the alcoholic cirrhotic.
Dig Dis Sci, 24 (1979), pp. 645-648
[28.]
G. Pinzello, R. Virdone, F. Locajono, M. Ciambra, G. Dardanoni, G. Fiorentino, et al.
Is the acidity of ascitic fluid a reliable index in making presumptive diagnosis of spontaneous bacterial peritonitis?.
Hepatology, 6 (1986), pp. 244-247
[29.]
J. Scemama-Clergue, C. Doutrellot-Philippon, J-M Metreau, B. Teisseire, D. Capron, D. Dhumeaux.
Ascitic fluid pH in alcoholic cirrhosis: a reevaluation of its use in the diagnosis of spontaneous bacterial peritonitis.
Gut, 26 (1985), pp. 332-335
[30.]
M. Navasa, J. Caballería, M. Elena, A.M. Ballesta, P. Ginés, J. Rodés.
Valor pronóstico del pH y del lactato en ascitis en la peritonitis bacteriana espontánea de la cirrosis hepática.
Gastroenterol Hepatol, 9 (1985), pp. 455-460
[31.]
P. Attali, K. Turner, G. Pelletier, O. Ink, J.P. Etienne.
PH of ascitic lfuid: diagnostic and prognostic value in cirrhotic and noncirrhotic patients.
Gastroenterology, 90 (1986), pp. 1255-1260
[32.]
B.A. Runyon, M.R. Antillon.
Ascitic fluid pH and lactate: insensitivity and nonspecific tests in detecting ascitic fluid infection.
Hepatology, 13 (1991), pp. 929-935
[33.]
J. Kammerer, C. Dupeyron, N. Vuillemin, G. Leluan, P. Fouet.
Apport des examens cytologiques et bacteriologiques du liquide d'ascite cirrhotique au diagnostic de peritonite bacterienne.
Med Chir Dig, 11 (1982), pp. 243-251
[34.]
M. Bobadilla, J. Sifuentes, G. García-Tsao.
Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis.
J Clin Microbiol, 27 (1989), pp. 2145-2147
[35.]
J. Castellote, X. Xiol, R. Verdaguer, J. Ribes, J. Guardiola, A. Giménez, et al.
Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis.
Am J Gastroenterol, 85 (1990), pp. 1605-1608
[36.]
B.A. Runyon, H.N. Canawati, E.A. Akriviadis.
Optimization of ascitic fluid culture technique.
Gastroenterology, 95 (1988), pp. 1351-1355
[37.]
B.A. Runyon, J.C. Hoefs.
Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid.
Hepatology, 4 (1984), pp. 447-450
[38.]
E.A. Akriviadis, B.A. Runyon.
Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis.
Gastroenterology, 98 (1990), pp. 127-133
[39.]
R. Terg, D. Levi, P. López, C. Rafaelli, S. Rotjer, R. Abecasis, et al.
Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease.
Dig Dis Sci, 37 (1992), pp. 1499-1504
[40.]
B.A. Runyon, J.C. Hoefs.
Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis.
Hepatology, 4 (1984), pp. 1209-1211
[41.]
G. Pelletier, D. Salmon, O. Ink, S. Hannoun, P. Attali, C. Buffet, et al.
Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis.
J Hepatol, 10 (1990), pp. 327-331
[42.]
B.A. Runyon.
Monomicrobial non-neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis.
Hepatology, 12 (1990), pp. 710-715
[43.]
G. Pelletier, G. Lesur, O. Ink, H. Hagege, P. Attali, C. Buffet, et al.
Asymptomatic bacterascites: is it spontaneous bacterial peritonitis?.
Hepatology, 14 (1991), pp. 112-115
[44.]
C-M Chu, K-Y Chang, Y-F. Liaw.
Prevalence and prognostic significance of bacteriascites in cirrhosis with ascites.
Dig Dis Sci, 40 (1995), pp. 561-565
[45.]
M. Forné, F. Bory, C. Sánchez, J.M. Viver.
Bacterascitis asintomática. Evolución favorable de un caso no tratado.
Gastroenterol Hepatol, 9 (1986), pp. 351-353
[46.]
R.N. Garrison, H.M. Cryer, D.A. Howard, H.C. Polk.
Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis.
Ann Surg, 199 (1984), pp. 648-655
[47.]
B.A. Runyon, J.C. Hoefs.
Spontaneous vs secondary bacterial peritonitis. Differentiation by response of ascitic fluid neutrophil count to antimicrobial therapy.
Arch Intern Med, 146 (1986),
[48.]
A. Follo, J.M. Llovet, M. Navasa, R. Planas, X. Forns, A. Francitorra, et al.
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.
Hepatology, 20 (1994), pp. 1495-1501
[49.]
B. Byl, I. Roucloux, A. Crusiaux, E. Dupont, J. Devière.
Tumor necrosis factor alpha and interleukin-6 plasma levels in infected cirrhotic patients.
Gastroenterology, 104 (1993), pp. 1492-1497
[50.]
F. Zeni, B. Tardy, M. Vindimian, C. Comtet, Y. Page, I. Cusey, et al.
High levels of tumor necrosis factor alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis.
Clin Infect Dis, 17 (1993), pp. 218-223
[51.]
T. Propst, A. Propst, M. Herold.
Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid.
Eur J Clin Invest, 23 (1993), pp. 832-836
[52.]
M. Navasa, A. Follo, X. Filella, W. Jiménez, A. Francitorra, R. Planas, et al.
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.
Hepatology, 27 (1998), pp. 1227-1232
[53.]
P. Sort, A. Cárdenas, M. Navasa.
Circulatory dysfunction induced by spontaneous bacterial peritonitis: mechanism and prevention.
Treatment of liver diseases, pp. 109-116
[54.]
P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, L Ruiz-del Arbol, et al.
Rodés Effec of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med, 341 (1999), pp. 403-409
[55.]
M. Navasa.
Advances in the treatment of spontaneous bacterial peritonitis.
Therapy in liver disease, pp. 407-410
[56.]
A. Rimola, F. Bory, J. Terés, R.M Pérez-Ayuso, V. Arroyo, J. Rodés.
Oral non-absorbable antibiotics prevent infection in cirrhosis with gastrointestinal hemorrhage.
Hepatology, 5 (1985), pp. 463-467
[57.]
G. Bleichner, R. Boulanger, P. Squara, J.P. Sollet, A. Parent.
Frequency of infections in cirrhotic patients presenting acute gastrointestinal haemorrhage.
Br J Surg, 73 (1986), pp. 724-726
[58.]
G. Soriano, C. Guarner, A. Tomás, C. Villanueva, X. Torras, D. González, et al.
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage.
Gastroenterology, 103 (1992), pp. 1267-1272
[59.]
M. Blaise, D. Pateron, J-C Trinchet, S. Levacher, M. Beaugrand, J-L. Pourriat.
Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage.
Hepatology, 20 (1994), pp. 34-38
[60.]
A. Pauwels, N. Mostefa-Kara, B. Debenes, E. Degoutte.
Lévy V-G. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infections.
Hepatology, 24 (1996), pp. 802-806
[61.]
W-J Hsieh, H-C Lin, S-J Hwang, M-V Hou, F-Y Lee, F-Y Chang, et al.
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis and upper gastrointestinal bleeding.
Am J Gastroenterol, 93 (1998), pp. 962-966
[62.]
B. Bernard, F.J. Cadranel, D. Valla, S. Escolano, V. Jarlier, P. Opolon.
Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.
Gastroenterology, 108 (1995), pp. 1828-1834
[63.]
J. Goulis, A. Armonis, D. Patch, C. Sabin, L. Greenslade, A.K. Burroughs.
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.
Hepatology, 27 (1998), pp. 1207-1212
[64.]
J. Goulis, D. Path, A.K. Burroughs.
Bacterial infections in the pathogenesis of variceal bleeding.
Lancet, 353 (1999), pp. 139-142
[65.]
L. Moreau, H. Durand, P. Biclet.
Cefotaxime concentrations in ascites.
J Antimicrob Chemother, 6 (1980), pp. 121-122
[66.]
J. Mercader, J. Gómez, J. Ruiz, M.C. Garre, M. Valdés.
Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients.
Chemotherapy, 35 (1989), pp. 23-26
[67.]
M.A. Mesquita, E.P.S. Balbino, R.S. Albuquerque, C.A. Carmona, B.T. Okubo, S.L.S. Loresa, et al.
Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear cell count response and short-term prognosis.
Hepato-Gastroenterology, 44 (1997), pp. 1276-1280
[68.]
J. Gómez-Jiménez, E. Ribera, J. Gasser, M.A. Artaza, O. DelValle, A. Pahissa, et al.
Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.
Antimicrob Agents Chemother, 37 (1993), pp. 1587-1592
[69.]
A. Rimola, L.l. Titó, J. Llach, J.M. Salmerón, F. Marqués, S. Badalamenti, et al.
Efficacy of ceftizoxime in the treatment of severe bacterial infections in patients with cirrhosis.
Drug Invest, 4 (1992), pp. 35-37
[70.]
P.A. McCormick, L. Greenslade, C.C. Kibbler, J.K. Chin, A.K. Burroughs, N. McIntyre.
A prospective randomized trial of ceftazidime versus netylmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.
Hepatology, 25 (1997), pp. 833-836
[71.]
J. Ariza, X. Xiol, M. Esteve, F. Fernández-Bañares, J. Liñares, T. Alonso, et al.
Aztreonam vs Cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
Hepatology, 14 (1991), pp. 91-98
[72.]
J. Cabrera, V. Arroyo, A.M. Ballesta, A. Rimola, J. Gual, M. Elena, et al.
Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary B2-microglobulin to discriminate functional renal failure from acute tubular damage.
Gastroenterology, 82 (1982), pp. 97-105
[73.]
J.D. Grange, X. Amiot, V. Grange, L. Gutmann, M. Biour, F. Bodin, et al.
Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients.
Hepatology, 11 (1990), pp. 360-364
[74.]
E. Ricart, G. Soriano, M.T. Novella, J. Ortiz, M. Sàbat, L. Kolle, et al.
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
J Hepatol, 32 (2000), pp. 596-602
[75.]
C. Silvain, J.P. Breux, G. Grollier, J. Rouffineau, B. Becq-Giraudon, M. Beauchant.
Les septicémies et les infections du liquide d'ascite du cirrhotique peuvent elles être traitées exclusivement par voie orale?.
Gastroenterol Clin Biol, 13 (1989), pp. 335-339
[76.]
P. Sort, P. Ginès, M. Navasa, V. Arroyo.
Tratamiento actual de la ascitis y la peritonitis bacteriana espontánea en España: análisis de una encuesta distribuida entre gastroenterólogos y hepatólogos.
Gastroenterol Hepatol, 20 (1997), pp. 437-441
[77.]
M. Navasa, J. Fernández, J. Rodés.
Bacterial infections in liver cirrhosis.
Ital J Gastroenterol Hepatol, 31 (1999), pp. 616-625
[78.]
T-L Fong, E.A. Akriviadis, B.A. Runyon, T.B. Reynolds.
Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis.
Hepatology, 9 (1989), pp. 423-426
[79.]
P. Ginès, M. Navasa.
Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?.
J Hepatol, 29 (1998), pp. 490-494
[80.]
M. Navasa, J. Fernández, V. Arroyo, J. Rodés.
Prophylaxis of bacterial infections in cirrhosis.
Treatment of liver diseases, pp. 103-108
[81.]
L.l. Tito, A. Rimola, P. Gines, J. Llach, V. Arroyo, J. Rodes.
Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.
Hepatology, 8 (1988), pp. 27-31
[82.]
J. Llach, A. Rimola, M. Navasa, P. Ginès, J.M. Salmerón, A. Ginès, et al.
Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.
Hepatology, 16 (1992), pp. 724-727
[83.]
M. Andreu, R. Solá, A. Sitges-Serra, C. Alia, M. Gallem, M.C. Vila, et al.
Risk factors for spontaneous bacterial peritonitis.
Gastroenterology, 104 (1993), pp. 1133-1138
[84.]
B. Bernard, J.D. Grangér, E. Nguyen Khac, X. Amiot, P. Opolon, T. Poynard.
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
Hepatology, 29 (1999), pp. 1655-1661
[85.]
G. Soriano, C. Guarner, M. Teixidó, J. Such, J. Barrios, Enríquez, et al.
Selective intestinal decontamination prevents spontaneous bacterial peritonitis.
Gastroenterology, 100 (1991), pp. 477-481
[86.]
M. Novella, R. Solà, G. Soriano, M. Andreu, J. Gana, J. Ortiz, et al.
Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Hepatology, 25 (1997), pp. 532-536
[87.]
J-D Grangé, D. Roulot, G. Pelletier, E-A Pariente, J. Denis, O. Ink, et al.
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
J Hepatol, 29 (1998), pp. 430-436
[88.]
A. Rolanchon, L. Cordier, Y. Bacq, J-B Nousbaum, A. Franza, J-C Paris, et al.
Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.
Hepatology, 22 (1995), pp. 1171-1174
[89.]
N. Singh, T. Gayowski, V.L. Yu, M.M. Wagener.
Trimethoprimsulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.
Ann Intern Med, 122 (1995), pp. 595-598
[90.]
B.A. Runyon.
Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.
Hepatology, 8 (1988), pp. 632-635
[91.]
B.A. Runyon.
Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis.
Gastroenterology, 91 (1986), pp. 1343-1346
[92.]
C. Guarner, R. Solà, G. Soriano, M. Andreu, M.T. Novella, M.C. Vila, et al.
Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels.
Gastroenterology, 117 (1999), pp. 414-419
[93.]
R. Terg, K. Llano, S.M. Cobas, C. Brotto, A. Barrios, D. Levi, et al.
Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short and long term administration with daily and weekly dosages.
J Hepatol, 29 (1998), pp. 437-442
[94.]
T. Alarcón, J. Pita, M. López-Brea, L.J.V. Piddock.
High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
J Antimicrob Chemother, 32 (1993), pp. 605-609
[95.]
C. Dupeyron, N. Mangeney, L. Sedrati, B. Campillo, P. Fouet, G. Leluan.
Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.
Antimicrob Agents Chemother, 38 (1994), pp. 340-344
[96.]
B. Campillo, C. Dupeyron, J-P Rchardet, N. Mangeney, G. Leluan.
Epidemiology of severe hospital-acquired in fections in patients with liver cirrhosis: effect of long-term administration of norfloxacin.
Clin Infect Dis, 26 (1998), pp. 1066-1070
[97.]
P. Ginès, A. Rimola, R. Planas, V. Vargas, F. Marco, M. Almela, et al.
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.
Hepatology, 12 (1990), pp. 716-724
[98.]
C. Altamn, J.D. Grangé, X. Amiot, G. Pelletier, F. Lacaine, F. Bodin, et al.
Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation.
J Gastroenterol Hepatol, 10 (1995), pp. 47-50
[99.]
D.J. Bac.
Spontaneous bacterial peritonitis: an indication for liver transplantation?.
Scand J Gastroenterol, 218 (1996), pp. 38-42
[100.]
B. Bernard, J.D. Grangé, E. Nguyen Khac, X. Amiot, P. Opolon, T. Poynard.
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis.
Digestion, 59 (1998), pp. 54-57
[101.]
J. Inadomi, A. Sonnenberg.
Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis.
Gastroenterology, 113 (1997), pp. 1289-1294
[102.]
Z.M. Younossi, J.G. McHutchinson, T.G. Ganiats.
An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis.
J Hepatol, 27 (1997), pp. 295-298
[103.]
A. Das.
A cost analysis of long-term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
Am J Gastroenterol, 93 (1998), pp. 1895-1900
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
